Response to: Is rituximab effective for IgG4-related disease in the long term? Experience of cases treated with rituximab for 4 years' by Yamamoto et al

John H. Stone, Mollie N. Carruthers, Mark D. Topazian, Arezou Khosroshahi, Thomas E. Witzig, Zachary S. Wallace, Phillip A. Hart, Vikram Deshpande, Thomas C. Smyrk, Suresh Chari

Research output: Contribution to journalLetter

Original languageEnglish (US)
Article numberA34
JournalAnnals of the rheumatic diseases
Volume74
Issue number8
DOIs
StatePublished - Aug 1 2015

ASJC Scopus subject areas

  • Immunology and Allergy
  • Rheumatology
  • Immunology
  • Biochemistry, Genetics and Molecular Biology(all)

Cite this

Stone, J. H., Carruthers, M. N., Topazian, M. D., Khosroshahi, A., Witzig, T. E., Wallace, Z. S., Hart, P. A., Deshpande, V., Smyrk, T. C., & Chari, S. (2015). Response to: Is rituximab effective for IgG4-related disease in the long term? Experience of cases treated with rituximab for 4 years' by Yamamoto et al. Annals of the rheumatic diseases, 74(8), [A34]. https://doi.org/10.1136/annrheumdis-2015-207640